Total Funding
56
54
Total FundingCorporate Round raised
Growth Score
-23 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
49342
Mosaic Therapeutics is an oncology therapeutics company that develops targeted combination therapies for cancer patients.
- Thomas Fuchs: Chief Executive OfficerPast Role: Cimeio Therapeutics, Chief Executive Officer
Vince O'Neill: Head of Research and DevelopmentPast Role: BioXcel Therapeutics, EVP, Head of Product Development and Medical Officer
About the Company
Mosaic Therapeutics is an oncology therapeutics company that develops targeted combination therapies for cancer patients. The company utilizes a proprietary platform to identify synergistic drug combinations based on biomarker-defined patient populations, aiming to improve the efficacy and durability of responses. Mosaic Therapeutics' research
focuses on identifying specific biomarkers that can be targeted with tailored drug combinations, enhancing the effectiveness of treatments for individual patients.
